The pooled effect size indicated significantly higher SP-D levels in the RA-ILD group compared to the RA group (MD = 78.59; 95% CI: 51.56-105.62; P < 0.001), with notable heterogeneity (I2 = 97.77%, P < 0.001). Here, HOXD13 is linked to rheumatoid arthritis.